SCHEMBL1583983

SCHEMBL1583983

CC(C)(C)OC(=O)NCCSSCCNC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 8/20 0.51
PPARG P37231 4/20 0.51
FABP2 P12104 2/20 0.51
SLC22A12 Q96S37 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.47
ALDH1A1 P00352 4/20 0.47
USP2 O75604 2/20 0.47
MAPT P10636 2/20 0.47
POLB P06746 2/20 0.47
HTT P42858 1/20 0.47
CNR1 P21554 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
LMNA P02545 2/20 0.46
TSHR P16473 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
MEN1 O00255 1/20 0.46
ABCB11 O95342 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12707617 0.94 PPARA (0.51) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL1584689 0.92 PPARA (0.56) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL22221443 0.90 PPARA (0.54) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL1584416 0.88 PPARA (0.52) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL1584922 0.87 PPARA (0.53) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL1584473 0.86 ALDH1A1 (0.54) PPARAPPARGFABP2SMN1; SMN2ALDH1A1
SCHEMBL1584444 0.86 PPARA (0.50) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL12707622 0.86 PPARA (0.50) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL22221670 0.81 PPARA (0.62) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL22221481 0.79 PPARA (0.60) PPARAPPARGFABP2SLC22A12SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011044141-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. (US) 2011-04-14 WO disclosed
US-20110082210-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2011-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110082210-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES FABP1, PPARA, FABP4 PPARA 2/4885PPARG 6/4885FABP2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.